InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by CUMMING JOHN W, Director. Officer active across 1 companies, notably T2 Biosystems, Inc.. Cumulatively, 5 reports have been recorded. Total volume traded: €36k. The latest transaction was disclosed on 1 July 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
81,967 shares
Common Stock
SEC:0000899243-22-024420:0·
€17,80418,182 shares@ €0.979279.35% mcap100.0% of flow
Common Stock
SEC:0000899243-21-027183·
€17,80418,182 shares@ €0.979279.35% mcap50.0% of flow
Common Stock
SEC:0000899243-21-027183:0·
45,454 shares
Common Stock
SEC:0000899243-21-026536·
45,454 shares
Common Stock
SEC:0000899243-21-026536:0·
5 of 5 declarations
About CUMMING JOHN W
John W. Cumming is a Board Member at T2 Biosystems, Inc. In this role, he contributes to the governance of the company by bringing his expertise in the health technology sector. John plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.
